Vertex Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:VRTX

Comments

Vertex Pharmaceuticals Inc Earnings Estimates

VRTXNASDAQ

Trade with Public

$441.20

At close: Apr 20, 5:00 PM EST

$443.30

2.100.48%

After Hours: Apr 17, 7:33 PM EST

Earnings: Q1 2026 Earnings in 14 days from now on Mon May 4th, after the market close

Overview NewsEarningsOptions Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Vertex Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:VRTX

Vertex Pharmaceuticals (VRTX) is scheduled to report Q1 earnings on May 4, 2026. Analysts estimate EPS of $4.13 and quarterly revenue of $3.01B.

In the most recent quarter (Q4), Vertex Pharmaceuticals reported EPS of $5.03, beating estimates of $4.85 by 0.04%. Revenue came in at $3.19B, exceeding the estimate of $3.17B by 0.01%.

Vertex Pharmaceuticals has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, Vertex Pharmaceuticals has averaged an EPS surprise of 0.08% and a revenue surprise of 0.02%.

Earnings Date

May 4

EPS Estimate

$4.130

Quarterly Revenue Estimate

$3.01B

Annual Revenue
(as of Dec 31)

$12.00B

Vertex Pharmaceuticals Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Loading calendar...

Vertex Pharmaceuticals (VRTX) Earnings Per Share

The chart below shows Vertex Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.

Vertex Pharmaceuticals (VRTX) Revenue

The chart below shows Vertex Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on May 4, 2026. The last reported earnings were for reported on February 12, 2026 for Q4.

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

The Actual EPS was $5.03, which beat the estimate of $4.85.

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

The Actual Revenue was $3.19B, which beat the estimate of $3.17B.

People Also Watch

BeOne Medicines Ltd

NASDAQ:ONC

$323.87

Neurocrine Biosciences Inc

NASDAQ:NBIX

$133.25

Ionis Pharmaceuticals Inc

United Therapeutics Corp

Vertex Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:VRTX

Vertex Pharmaceuticals (VRTX) is scheduled to report Q1 earnings on May 4, 2026. Analysts estimate EPS of $4.13 and quarterly revenue of $3.01B.

In the most recent quarter (Q4), Vertex Pharmaceuticals reported EPS of $5.03, beating estimates of $4.85 by 0.04%. Revenue came in at $3.19B, exceeding the estimate of $3.17B by 0.01%.

Vertex Pharmaceuticals has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, Vertex Pharmaceuticals has averaged an EPS surprise of 0.08% and a revenue surprise of 0.02%.

Earnings Date

May 4

EPS Estimate

$4.130

Quarterly Revenue Estimate

$3.01B

Annual Revenue
(as of Dec 31)

$12.00B